A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia

Published:2012-11-23 Issue:1 Volume:20 Page:1-7
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Zhang L-N,Li J-Y,Xu W

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt201284.pdf

Reference86 articles.

1. Chiorazzi N, Hatzi K, Albesiano E . B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann NY Acad Sci 2005; 352: 804–815.

2. Caligaris-Cappio F, Hamblin TJ . B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999; 17: 399–408.

3. Strasser A . The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005; 5: 189–200.

4. Huang DC, Strasser A . BH3-Only proteins-essential initiators of apoptotic cell death. Cell 2000; 103: 839–842.

5. Elkholi R, Floros KV, Chipuk JE . The role of BH3-only proteins in tumor cell development, signaling, and treatment. Genes Cancer 2011; 2: 523–537.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF;Pathology - Research and Practice;2023-02

2. Endoplasmic Reticulum Stress Causing Apoptosis in a Mouse Model of an Ischemic Spinal Cord Injury;International Journal of Molecular Sciences;2023-01-09

3. Targeting Apoptosis in AML: Where Do We Stand?;Cancers;2022-10-12

4. MY11 exerts antitumor effects through activation of the NF-κB/PUMA signaling pathway in breast cancer;Investigational New Drugs;2022-06-27

5. DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer;Frontiers in Oncology;2022-05-13